Centre allows Bharat Biotech to begin commercial exports of Covaxin

Coronavirus Vaccine | Bharat Biotech | Trade exports
Sohini Das  |  Mumbai 

Paving the way for commercial exports of Covid-19 vaccines to start from India, the Centre allowed Hyderabad-based vaccine maker Bharat Biotech to start commercial exports of Covaxin on Tuesday, according to sources in the know. A few days back, its peer Pune’s Serum Institute of India (SII), was allowed to export to the WHO-led vaccine initiative COVAX.
Bharat Biotech did not wish to comment on the matter. SII, too, did not confirm if it got a nod to start commercial bilateral exports from the Indian government. Bharat Biotech made 55 million doses of Covaxin in October, …
Key stories on business-standard.com are available to premium subscribers only.
Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.
Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor
Copyrights © 2021 Business Standard Private Ltd. All rights reserved.
Business Standard
Upgrade To Premium Services
Business Standard is happy to inform you of the launch of “Business Standard Premium Services”
As a premium subscriber you get an across device unfettered access to a range of services which include:
Business Standard
Premium Services
In Partnership with Fis Logo
Dear Guest,
Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard



Leave a Reply

Your email address will not be published. Required fields are marked *

  ⁄  one  =  eight

Next Post

SC re-imposes ban on construction in Delhi-NCR as air quality worsens

Thu Nov 25 , 2021
Topics Supreme Court | Delhi-NCR | Delhi air quality Press Trust of India  |  New Delhi  Last Updated at November 25, 2021 13:11 IST https://mybs.in/2Zj61Ep Taking note of worsening air quality, the Supreme Court has re-imposed the ban on construction activities in Delhi and national capital region (NCR) and directed the states to provide […]